Gout: Where Is the Weak Link?

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
Eliseo PascualFrancisca Sivera

Abstract

In the field of rheumatic and musculoskeletal diseases, no other condition has evolved so significantly since the mid-1950s as gout. In this period, the cause of gout has been firmly established; the close relationship with other conditions clarified; a rapid, unequivocal diagnostic test established; and agents effective in dissolving monosodium urate crystals and controlling inflammation made widely available. All these insights have ultimately led to deem gout as curable, an end point formerly considered out of reach. Unfortunately, diagnosis and management of gout in clinical practice have not paralleled the scientific advances and remain far from established quality standards. This paradox is the topic of the present review article, intending to increase the widespread interest of clinicians in gout.

References

May 10, 1977·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·T KametaniT Haba
May 1, 1973·Annals of Internal Medicine·D J McCarty
Jan 1, 1981·Nephron·J W LinnaneB T Emmerson
Dec 1, 1996·Annals of the Rheumatic Diseases·J C GersterP Schnyder
Nov 30, 1999·Annals of Internal Medicine·E PascualP Vela
Sep 5, 2002·Arthritis and Rheumatism·Fernando Perez-RuizAna Ruibal
Nov 13, 2002·Arthritis and Rheumatism·R Clive LandisDorian O Haskard
Mar 1, 1961·Annals of Internal Medicine·D J MCCARTY, J L HOLLANDER
Jan 6, 1951·Journal of the American Medical Association·R D FRIEDLANDER
Dec 1, 1951·The American Journal of Medicine·T F YU, A B GUTMAN
Jun 21, 1952·Journal of the American Medical Association·W C KUZELLE A MANKLE
Jul 1, 1950·The American Journal of Medicine·A B GUTMAN, T F YU
Mar 17, 2005·Annals of the Rheumatic Diseases·B LumbrerasI Hernández-Aguado
Jan 13, 2006·Nature·Fabio MartinonJürg Tschopp
May 19, 2006·Annals of the Rheumatic Diseases·W ZhangUNKNOWN EULAR Standing Committee for International Clinical Studies Including Therapeutics
Jul 28, 2006·Arthritis and Rheumatism·Eswar KrishnanH Ralph Schumacher
Aug 19, 2007·Circulation·Hyon K Choi, Gary Curhan
Mar 1, 1945·Annals of the Rheumatic Diseases·G L Steinberg
Sep 1, 1946·Annals of the Rheumatic Diseases·L C Hill
Jan 7, 2009·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Aarti MalikGilda M Clayburne
Feb 5, 2010·Arthritis and Rheumatism·Nicola DalbethJillian Cornish
Dec 17, 2010·Journal of Developmental and Behavioral Pediatrics : JDBP·Priti P Desai, Prerana Mohite
Sep 29, 2011·Annals of the Rheumatic Diseases·Eugenio De MiguelEmilio Martín-Mola
Nov 28, 2013·European Journal of Preventive Cardiology·L E ClarsonC D Mallen
Sep 2, 2014·The Cochrane Database of Systematic Reviews·Francisca SiveraLoreto Carmona
Sep 16, 2015·Nature Reviews. Rheumatology·Eliseo PascualFrancisca Sivera
Jan 27, 2017·Annals of the Rheumatic Diseases·Mark C FisherHyon K Choi
Oct 1, 2018·Annals of the Rheumatic Diseases·Thomas BardinJean-Michel Correas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Duodecim; lääketieteellinen aikakauskirja
H Isomäki
The Medical and Physical Journal
Zeitschrift für Allgemeinmedizin
M Schattenkirchner
Nihon rinsho. Japanese journal of clinical medicine
S Sasaki
Nederlands tijdschrift voor tandheelkunde
P Bol
© 2021 Meta ULC. All rights reserved